vTv Therapeutics (VTVT) Receivables (2016 - 2024)
Historic Receivables for vTv Therapeutics (VTVT) over the last 10 years, with Q4 2024 value amounting to $62000.0.
- vTv Therapeutics' Receivables fell 3921.57% to $62000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $62000.0, marking a year-over-year decrease of 3921.57%. This contributed to the annual value of $62000.0 for FY2024, which is 3921.57% down from last year.
- As of Q4 2024, vTv Therapeutics' Receivables stood at $62000.0, which was down 3921.57% from $242000.0 recorded in Q3 2024.
- In the past 5 years, vTv Therapeutics' Receivables registered a high of $981000.0 during Q1 2024, and its lowest value of $2000.0 during Q1 2021.
- In the last 5 years, vTv Therapeutics' Receivables had a median value of $77000.0 in 2022 and averaged $214733.3.
- As far as peak fluctuations go, vTv Therapeutics' Receivables soared by 652857.14% in 2021, and later plummeted by 9385.78% in 2022.
- Over the past 5 years, vTv Therapeutics' Receivables (Quarter) stood at $158000.0 in 2020, then tumbled by 63.92% to $57000.0 in 2021, then soared by 203.51% to $173000.0 in 2022, then plummeted by 41.04% to $102000.0 in 2023, then crashed by 39.22% to $62000.0 in 2024.
- Its Receivables was $62000.0 in Q4 2024, compared to $242000.0 in Q3 2024 and $306000.0 in Q2 2024.